Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
Pollak TA. et al, (2021), Mol Psychiatry, 26, 2590 - 2604
Real-world prevalence of autoantibodies in epilepsy
McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61
Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls
Theorell J. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 385 - 385